Thank you, Peter. For the fourth quarter, all three segments contributed to ASGN's growth. The Apex Segment, which Rand will review in a few moments, grew 13.1% year-over-year and the Oxford segment grew 4.8% from the fourth quarter of last year. The Apex and Oxford markets we serve in IT, Digital/Creative Marketing, Life Sciences and Engineering, all remained stable and productive during and exiting the quarter. Secular changes remain in our favor with regards to how our customers are evolving their approach to supporting business needs and getting projects completed. While our staffing services continue to grow, and we take share with greater than market growth rates, our value-added service offerings or consultative work are growing at a much faster pace. The Oxford Segment is comprised of Oxford Core, CyberCoders, our permanent placement business, and Life Sciences Europe. For the fourth quarter of 2018, Oxford Segment revenues were $151.2 million up 4.8% year-over-year, or 5.5% on a constant currency basis. For the full 2018 year, the Oxford segment generated $606.5 million in revenues and was up 3% year-over-year with all units positively contributing to growth. Oxford Core revenues, which account for approximately 75.5% of the segment revenues, were up approximately 5.6% year-over-year, or 6.1% on a constant currency basis and in line with our expectations. CyberCoders, our permanent placement service offering, which accounts for 97.4% of the segment's permanent placement revenues, had 4.1% growth year-over-year, meeting our initial expectations. Gross margin for the segment was 40.7% coming in slightly ahead of initial expectations for the quarter, but down 110 basis points year-over-year due in large part to business mix within the segment. As we typically do, let me give some color to the progress in Oxford Core. In 2018, Oxford Core returned to a position of year-over-year growth, ending the year with the highest quarterly year-over-year growth rate. Q4 showed varying degrees of performance in each of our four disciplines in the U.S. and Europe with strong growth in our domestic IT and Engineering offerings, along with strong growth in our European business. It is a longer road to truly institutionalize our sales strategies and build upon the productivity we have created over the last few quarters. However, we are pleased with the progress we have shown during the course of 2018 and our results provide us confidence that our actions will lead to continued growth, increased productivity and consistently improving bottom-line results. In 2019, the results of our Life Sciences Europe division, the smallest division within the Oxford Segment and ASGN, will be incorporated within the overall Oxford Core results and we will continue to provide commentary on the performance of that business unit both in the United States and in Europe. I will now turn the call over to Rand Blazer. Rand?